![Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome | SpringerLink Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12185-023-03532-y/MediaObjects/12185_2023_3532_Fig1_HTML.jpg)
Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome | SpringerLink
Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. - Document - Gale OneFile: Health and Medicine
![Study Reveals New Insights Into Predictors of Mortality in Patients With VEXAS Syndrome - Hematology Advisor Study Reveals New Insights Into Predictors of Mortality in Patients With VEXAS Syndrome - Hematology Advisor](https://www.hematologyadvisor.com/wp-content/uploads/sites/14/2021/11/stem-cells_G_1340129773-860x573.jpg)
Study Reveals New Insights Into Predictors of Mortality in Patients With VEXAS Syndrome - Hematology Advisor
![Pulmonary Manifestations in VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: A Systematic Literature Review - ACR Meeting Abstracts Pulmonary Manifestations in VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: A Systematic Literature Review - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2022/09/1279537_1.jpg)
Pulmonary Manifestations in VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: A Systematic Literature Review - ACR Meeting Abstracts
![Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome - CHEST Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome - CHEST](https://journal.chestnet.org/cms/asset/6b0adea7-97a4-45ab-b368-2e5201437c82/gr3.jpg)
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome - CHEST
![Características clínicas y moleculares de un nuevo síndrome reumatológico recientemente descripto: el Síndrome de VEXAS - Cibic Laboratorios Características clínicas y moleculares de un nuevo síndrome reumatológico recientemente descripto: el Síndrome de VEXAS - Cibic Laboratorios](https://www.cibic.com.ar/wp-content/uploads/2022/06/rsz_dsc_0158.jpg)
Características clínicas y moleculares de un nuevo síndrome reumatológico recientemente descripto: el Síndrome de VEXAS - Cibic Laboratorios
![A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML | Leukemia A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01698-8/MediaObjects/41375_2022_1698_Fig1_HTML.png)
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML | Leukemia
![El síndrome de vexas, una extraña enfermedad inflamatoria, sería más frecuente de lo que se creía, sugiere estudio El síndrome de vexas, una extraña enfermedad inflamatoria, sería más frecuente de lo que se creía, sugiere estudio](https://cnnespanol.cnn.com/wp-content/uploads/2023/01/230123170036-david-adams-vesas-syndrome.jpg?quality=100&strip=info)
El síndrome de vexas, una extraña enfermedad inflamatoria, sería más frecuente de lo que se creía, sugiere estudio
Twitter 上的 Sophie Georgin-Lavialle:"The French cohort of 116 VEXAS syndrome is online! A great work in a few months! Thanks to all contributors !! A fascinating new disease! @BrJDermatol @mekinian2 @TerrierBen @contactfai2r @
![Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry - Comont - 2022 - British Journal of Haematology - Wiley Online Library Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry - Comont - 2022 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/de85ec9b-1453-445a-b180-d1874c741c17/bjh.v196.4.cover.jpg?trick=1687674490738)
Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry - Comont - 2022 - British Journal of Haematology - Wiley Online Library
![Break down the barriers of auto‐inflammation: How to deal with a monogenic auto‐inflammatory disease and immuno‐haematological features in 2022? - Vergneault - 2023 - Immunology - Wiley Online Library Break down the barriers of auto‐inflammation: How to deal with a monogenic auto‐inflammatory disease and immuno‐haematological features in 2022? - Vergneault - 2023 - Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/83615e44-abc7-478f-b84a-59c073f3f54e/imm13579-fig-0004-m.jpg)